Misonix, Inc. (Nasdaq: MSON) designs, develops, manufactures and markets ultrasonic medical devices for the precise removal of hard and soft tissue, including bone removal, wound debridement and ultrasonic aspiration. Our proprietary ultrasonic medical devices are used in a growing number of medical procedures, including spine surgery, neurosurgery, orthopedic surgery, cosmetic surgery, laparoscopic surgery, and other surgical and medical applications.
At Misonix, Better Matters to us. That is why throughout the Company’s history, Misonix has maintained its commitment to medical technology innovation and the development of ultrasonic surgical products with demonstrated clinical benefits that radically improve patient outcomes. With sales distribution to major surgical markets in over 45 countries, Misonix remains focused on becoming the standard of care in operating rooms and clinics around the world, while positioning the business for long-term growth and the enhancement of shareholder value.